Bo Gamble, director of Strategic Practice Initiatives at the Community Oncology Alliance (COA), explains how COA plays a role in supporting practices in preparing for Oncology Care Model.
Bo Gamble, director of Strategic Practice Initiatives at the Community Oncology Alliance (COA), explains how COA plays a role in supporting practices in preparing for Oncology Care Model.
Transcript
How has COA played a role in helping smaller practices prepare for OCM?
We’re trying to create a platform for dialogue. What we’ve found historically—even Medicare, for example, is 50 years, it’s the same program over and over again—payers do the same thing over and over again. Even when you’re an employer and you’re like, "Here’s your benefit package," and you’re like, "Ahh" or "It’s okay, but the premiums are going up." We got to change this concept because we’re just going in the opposite direction.
So the notion of this program, and we have been working on reform now for 6 or 7 years, the [COA Payer Exchange Summit] is a platform is to engage the others. So if you’re part of a care team, the price of admission you must bring a payer or employer and if you’re a payer or employer looking for options you got to bring someone in from a care team. The concept is helping to bring down the walls and it’s exciting because we’re in a place where we’re talking about a place where we’ve never talked before. We haven’t figured it out yet but we’re making progress.
If you look at 6 years ago, the buzzword was pathways, pathways, pathways. It became a component, but it’s not the component. Which is good. There’s other things and we continue to get smarter about what we think’s important in care, in quality, in value and we’re starting to agree on come components. Now the trick is let’s do it efficiently, so it’s the same model, we’re just changing how it’s looked. We have to change optics because there’s still those little fires that pop up, that says, "Here’s what we’re doing," and their motive and their incentive or their understanding is just way off base. So we have a lot of education to do.
Advances in Gene Therapy, Neuroregeneration at the Forefront of MDA 2025
March 13th 2025Look ahead to this year's Muscular Dystrophy Association (MDA) meeting, which will feature discussions on the latest gene therapies, clinical trial data, policy considerations, and more in the realm of neuromuscular disease.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
VBID, Heading Into a Third Decade, Looks to Promote Personalization and Access
March 12th 2025Speakers at the 2025 Value-Based Insurance Design summit recapped the accomplishments made over the past 20 years in designing insurance benefits with value in mind and looked ahead to iterations to come.
Read More